Mounjaro side effects: What to expect
Relevant for clinical practice, our findings show that treatment with semaglutide lowered the risk of MACE compared to sitagliptin, while tirzepatide showed at least comparable benefit to dulaglutide, an older GLP-1 receptor agonist with established cardiovascular efficacy
This has also led to increasing comparisons with newer therapies, particularly in discussions around semaglutide vs tirzepatide, where differences in mechanism and efficacy are actively evaluated
Some patients experience nausea, vomiting, or other gastrointestinal symptoms that lead them to reduce food intake of nutrient-dense foods while increasing simple carbohydrates for symptom management, potentially negating metabolic benefits
Typically 5-15 business days from submission
Altogether, the GLP-1R signaling pathway is essential for reducing neuroinflammation by regulating microglia function and polarization [114]